This week’s news from the life sciences includes Eli Lilly's investment in a Cambridge-Singapore biotech, Stealth ...

Eli Lilly's valuation could look much more modest in the future, as its earnings should continue to grow at a high rate.

There's no playbook for how to be competitive in artificial intelligence (AI) as a big pharma company, but Eli Lilly (NYSE: ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Meanwhile, its other large-cap fund (QRAFT), which isn’t geared toward momentum stocks, has zero exposure to the chip maker.

Clea Shearer, star of the Netflix show “Get Organized with The Home Edit,” discussed her breast cancer journey after ...

Eli Lilly’s senior VP of information and R&D IT, Ramesh Durvasula, said Lilly will use AI and tech to transform the company.

Eli Lilly's weight-loss drug is no longer on the Food and Drug Administration's drug shortage list. Compounding pharmacies say this will limit patient access.

The U.K. will study whether Lilly's weight loss drug can get people back to work and help tackle long-term sickness ...

Severe malnutrition is treated with ready-to-use therapeutic food, a paste combining peanuts, sugar, milk powder, oil, ...

Unfortunately, many of our elected leaders today undervalue the role of patents to progress the science of drug discovery and ...